Vortioxetine for treatment of depression

Published on 04 Jun 2024
Last Updated on 04 Jun 2024

Guidance Recommendations

The Ministry of Health’s Drug Advisory Committee has not recommended vortioxetine for inclusion on the MOH List of Subsidised Drugs for treatment of depression. This decision was due to unfavourable cost effectiveness compared with subsidised alternative treatments, based on the price proposal from the manufacturer.

Vortioxetine for treatment of depression (Published 4 Jun 24) [PDF, 88 KB]